- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hemostatic Agents in New Zealand
Total 1073 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Neurotoxicity | Neuropathy | Chemotherapeutic Agent ToxicityUnited States, Puerto Rico
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthAmgenRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Yale UniversityCompleted
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of RochesterTerminatedMultiple MyelomaUnited States
-
University of RochesterNational Cancer Institute (NCI)RecruitingMyelomaUnited States
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
NYU Langone HealthCephalonTerminated
-
ChimerixActive, not recruiting
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyAnorMEDTerminatedMultiple MyelomaUnited States
-
AttenuonTerminated
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedColorectal Cancer | Anal Cancer | Drug/Agent Toxicity by Tissue/Organ | Radiation EnteritisUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
CephalonTerminated
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedMultiple MyelomaUnited States
-
Celularity IncorporatedCompleted
-
Seagen Inc.Terminated
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Yale UniversityCelgene; Kyowa Kirin Co., Ltd.Completed
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple Myeloma | Auto Stem Cell TransplantUnited States
-
Dartmouth-Hitchcock Medical CenterThe Leukemia and Lymphoma SocietyCompletedMyeloma | Transplant-eligible PatientsUnited States
-
Larysa SanchezJanssen, LPRecruitingNewly Diagnosed Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
Sorrento Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; GlaxoSmithKline and other collaboratorsCompletedMultiple MyelomaUnited States
-
Baxter Healthcare CorporationCompletedHemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft ProsthesesUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States